OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 239
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 239
Showing 1-25 of 239 citing articles:
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 20
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 20
Carbon Dot Based Carbon Nanoparticles as Potent Antimicrobial, Antiviral, and Anticancer Agents
Narmin Hamaamin Hussen, Aso Hameed Hasan, Yar Muhammed FaqiKhedr, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 9849-9864
Open Access | Times Cited: 18
Narmin Hamaamin Hussen, Aso Hameed Hasan, Yar Muhammed FaqiKhedr, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 9849-9864
Open Access | Times Cited: 18
Research progress of organic photothermal agents delivery and synergistic therapy systems
Yuan Li, Haolong Qi, Yingjie Geng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 234, pp. 113743-113743
Closed Access | Times Cited: 15
Yuan Li, Haolong Qi, Yingjie Geng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 234, pp. 113743-113743
Closed Access | Times Cited: 15
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
Natalia I. Agalakova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 945-945
Open Access | Times Cited: 12
Natalia I. Agalakova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 945-945
Open Access | Times Cited: 12
Cyclodextrin-based nanocarriers as promising scaffolds for overcoming challenges of doxorubicin delivery in cancer chemotherapy
Sara Payamifar, Amin Foroozandeh, Mehrab Pourmadadi, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100677-100677
Open Access | Times Cited: 1
Sara Payamifar, Amin Foroozandeh, Mehrab Pourmadadi, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100677-100677
Open Access | Times Cited: 1
Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189024-189024
Open Access | Times Cited: 24
Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189024-189024
Open Access | Times Cited: 24
Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo–Yap pathway to exacerbate doxorubicin-induced cardiotoxicity
Peng Zhao, Li You, Xiangli Xu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
Peng Zhao, Li You, Xiangli Xu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
Oxidative Stress and Age-Related Tumors
Emma Di Carlo, Carlo Sorrentino
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1109-1109
Open Access | Times Cited: 8
Emma Di Carlo, Carlo Sorrentino
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1109-1109
Open Access | Times Cited: 8
Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
Roberta Vitale, Stefania Marzocco, Ada Popolo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7477-7477
Open Access | Times Cited: 7
Roberta Vitale, Stefania Marzocco, Ada Popolo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7477-7477
Open Access | Times Cited: 7
Chromatin as an old and new anticancer target
Jacques Neefjes, Katerina V. Gurova, Jay F. Sarthy, et al.
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 696-707
Open Access | Times Cited: 6
Jacques Neefjes, Katerina V. Gurova, Jay F. Sarthy, et al.
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 696-707
Open Access | Times Cited: 6
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Protection of Bortezomib Via Beta-Hydroxy Ketone Skeleton in Doxorubicin and the Interaction with Bovine Serum Albumin: Spectroscopic and Molecular Docking Studies
Shan Qiao, Yun S. Song, Dong Xu, et al.
(2025)
Closed Access
Shan Qiao, Yun S. Song, Dong Xu, et al.
(2025)
Closed Access
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
Alberto Gabizón, Shira Gabizon–Peretz, Shadan Modaresahmadi, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000573-e000573
Open Access
Alberto Gabizón, Shira Gabizon–Peretz, Shadan Modaresahmadi, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000573-e000573
Open Access
GV1001, hTERT Peptide Fragment, Prevents Doxorubicin-Induced Endothelial-to-Mesenchymal Transition in Human Endothelial Cells and Atherosclerosis in Mice
W Chen, Seo‐Jin Kim, Sharon Kim, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 98-98
Open Access
W Chen, Seo‐Jin Kim, Sharon Kim, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 98-98
Open Access
Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities
Kun Li, Kunmao Jiang, Yu Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114016-114016
Closed Access
Kun Li, Kunmao Jiang, Yu Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114016-114016
Closed Access
Triple-Negative Breast Cancer Aptamer-Targeting Porous Silicon Nanocarrier
Ankit Malhotra, Pouya Dehghankelishadi, Ishdeep Kaur, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Ankit Malhotra, Pouya Dehghankelishadi, Ishdeep Kaur, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Mitochondrial segmentation and function prediction in live-cell images with deep learning
Yang Ding, Jintao Li, Jiaxin Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Yang Ding, Jintao Li, Jiaxin Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance
Hanan Elimam, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Hanan Elimam, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Enhancing hepatocellular carcinoma therapy with DOX-loaded SiO2 nanoparticles via mTOR-TFEB pathway autophagic flux inhibition
Huanyu Chen, Jun Liu, Zhichao Cao, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Huanyu Chen, Jun Liu, Zhichao Cao, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
An effective cell-penetrating peptide-based loading method to extracellular vesicles and enhancement in cellular delivery of drugs
Jin Zhang, Ning Su, Wei Liu, et al.
Analytical and Bioanalytical Chemistry (2025)
Closed Access
Jin Zhang, Ning Su, Wei Liu, et al.
Analytical and Bioanalytical Chemistry (2025)
Closed Access
Exploiting novel placental homing peptides for targeted drug delivery in breast Cancer
Abdulaziz A. Alobaid, Harmesh Aojula, Richard A. Campbell, et al.
Nanomedicine Nanotechnology Biology and Medicine (2025), pp. 102805-102805
Closed Access
Abdulaziz A. Alobaid, Harmesh Aojula, Richard A. Campbell, et al.
Nanomedicine Nanotechnology Biology and Medicine (2025), pp. 102805-102805
Closed Access
Signal amplification of low concentration doxorubicin detection using the impact electrochemistry of Cu-Co bimetallic nanoparticles with CN vacancies
Haosen Xiong, Shihan Zhang, Wensheng Liao, et al.
Microchemical Journal (2025), pp. 112854-112854
Closed Access
Haosen Xiong, Shihan Zhang, Wensheng Liao, et al.
Microchemical Journal (2025), pp. 112854-112854
Closed Access
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects
Maria Auxiliadora Parreiras Martins, Francisco Veiga, Ana Cláudia Paiva‐Santos, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Maria Auxiliadora Parreiras Martins, Francisco Veiga, Ana Cláudia Paiva‐Santos, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity
Jhon Jairo Osorio-Méndez, Luis Alberto Gómez, Gladis Montoya-Ortiz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 945-945
Open Access
Jhon Jairo Osorio-Méndez, Luis Alberto Gómez, Gladis Montoya-Ortiz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 945-945
Open Access
In Vitro Potentiation of Doxorubicin Cytotoxicity Utilizing Clarithromycin Loaded-PEGylated Liposomes
Islam Alfreahat, Hamdi Nsairat, Ibrahim Al‐Deeb, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Islam Alfreahat, Hamdi Nsairat, Ibrahim Al‐Deeb, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
